Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19

An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confir...

Full description

Saved in:
Bibliographic Details
Published inHealth and quality of life outcomes Vol. 19; no. 1; pp. 40 - 10
Main Authors Machado, Felipe V. C., Meys, Roy, Delbressine, Jeannet M., Vaes, Anouk W., Goërtz, Yvonne M. J., van Herck, Maarten, Houben-Wilke, Sarah, Boon, Gudula J. A. M., Barco, Stefano, Burtin, Chris, van ’t Hul, Alex, Posthuma, Rein, Franssen, Frits M. E., Spies, Yvonne, Vijlbrief, Herman, Pitta, Fabio, Rezek, Spencer A., Janssen, Daisy J. A., Siegerink, Bob, Klok, Frederikus A., Spruit, Martijn A.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 03.02.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
AbstractList An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. Keywords: SARS-CoV-2, Functional status, Symptoms, Quality of life
Abstract Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing ‘slight’, ‘moderate’ and ‘severe’ functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing ‘negligible’ and ‘no’ functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233–0.661). Notably, the strongest association found was with the ‘usual activities’ domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing ‘slight’, ‘moderate’ and ‘severe’ functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing ‘negligible’ and ‘no’ functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233–0.661). Notably, the strongest association found was with the ‘usual activities’ domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.BACKGROUNDAn increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.METHODSAdult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.RESULTS1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.CONCLUSIONWe demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
ArticleNumber 40
Audience Academic
Author Vaes, Anouk W.
Meys, Roy
Houben-Wilke, Sarah
Boon, Gudula J. A. M.
Spies, Yvonne
Vijlbrief, Herman
Rezek, Spencer A.
van Herck, Maarten
Posthuma, Rein
Klok, Frederikus A.
Delbressine, Jeannet M.
van ’t Hul, Alex
Franssen, Frits M. E.
Siegerink, Bob
Pitta, Fabio
Burtin, Chris
Janssen, Daisy J. A.
Goërtz, Yvonne M. J.
Spruit, Martijn A.
Barco, Stefano
Machado, Felipe V. C.
Author_xml – sequence: 1
  givenname: Felipe V. C.
  orcidid: 0000-0003-1910-7695
  surname: Machado
  fullname: Machado, Felipe V. C.
– sequence: 2
  givenname: Roy
  surname: Meys
  fullname: Meys, Roy
– sequence: 3
  givenname: Jeannet M.
  surname: Delbressine
  fullname: Delbressine, Jeannet M.
– sequence: 4
  givenname: Anouk W.
  surname: Vaes
  fullname: Vaes, Anouk W.
– sequence: 5
  givenname: Yvonne M. J.
  surname: Goërtz
  fullname: Goërtz, Yvonne M. J.
– sequence: 6
  givenname: Maarten
  surname: van Herck
  fullname: van Herck, Maarten
– sequence: 7
  givenname: Sarah
  surname: Houben-Wilke
  fullname: Houben-Wilke, Sarah
– sequence: 8
  givenname: Gudula J. A. M.
  surname: Boon
  fullname: Boon, Gudula J. A. M.
– sequence: 9
  givenname: Stefano
  surname: Barco
  fullname: Barco, Stefano
– sequence: 10
  givenname: Chris
  surname: Burtin
  fullname: Burtin, Chris
– sequence: 11
  givenname: Alex
  surname: van ’t Hul
  fullname: van ’t Hul, Alex
– sequence: 12
  givenname: Rein
  surname: Posthuma
  fullname: Posthuma, Rein
– sequence: 13
  givenname: Frits M. E.
  surname: Franssen
  fullname: Franssen, Frits M. E.
– sequence: 14
  givenname: Yvonne
  surname: Spies
  fullname: Spies, Yvonne
– sequence: 15
  givenname: Herman
  surname: Vijlbrief
  fullname: Vijlbrief, Herman
– sequence: 16
  givenname: Fabio
  surname: Pitta
  fullname: Pitta, Fabio
– sequence: 17
  givenname: Spencer A.
  surname: Rezek
  fullname: Rezek, Spencer A.
– sequence: 18
  givenname: Daisy J. A.
  surname: Janssen
  fullname: Janssen, Daisy J. A.
– sequence: 19
  givenname: Bob
  surname: Siegerink
  fullname: Siegerink, Bob
– sequence: 20
  givenname: Frederikus A.
  surname: Klok
  fullname: Klok, Frederikus A.
– sequence: 21
  givenname: Martijn A.
  surname: Spruit
  fullname: Spruit, Martijn A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33536042$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wB1ggS2xgkeJH_MgGqRpaGKlSEQNsLcePGY8ycYnt0v57nE5bOhVCXtiyv3N8fX0Oq70hDLaqXiN4jJBgHyLCLaU1xKiGiLWoxs-qA9RwXnOK6d6j9X51GOMaQkwwpi-qfUIoYbDBB5WchSGmMesErlTvjU83IDiQVhZ8DTHVs4uf8081asFZHnTyYVA9WCSVcgQLrXoL_ACUyX0CMXdrq1MEv31agXvdy-q5U320r-7mo-rH2en32Zf6_OLzfHZyXmva8lQz2iChBKWu0diKDhsnoLDEwK5hSqiGGwwdYw5pYy1xHcFdI5igiLfCWEyOqvnW1wS1lpej36jxRgbl5e1GGJdSjcnr3srycs1Ry3SHYLkVt85iqBtDO844Qrx4fdx6XeZuY422QxpVv2O6ezL4lVyGK8kFZQxPxby7MxjDr2xjkhsfte17NdiQo8Sl9IZhQUhB3z5B1yGPpcsT1aIGlweiv9SytFz6wYVyr55M5QkrXykI4lPdx_-gyjB243XJjvNlf0fwfkdQmGSv01LlGOV88W2XffO4KQ_duI9SAfAW0GOIcbTuAUFQTnmV27zKkld5m1c5icQTkfYlXSVnpXTf_0_6B39I6cM
CitedBy_id crossref_primary_10_3389_fresc_2023_1186499
crossref_primary_10_1007_s10554_023_02819_9
crossref_primary_10_22289_2446_922X_V10N1A31
crossref_primary_10_1136_bmjgh_2021_006838
crossref_primary_10_1371_journal_pone_0312735
crossref_primary_10_1590_1980_5764_dn_2021_0116
crossref_primary_10_12688_f1000research_133999_1
crossref_primary_10_12688_f1000research_133999_2
crossref_primary_10_1093_cid_ciad143
crossref_primary_10_3390_ijerph19159273
crossref_primary_10_3390_brainsci11111456
crossref_primary_10_3390_ijerph18116017
crossref_primary_10_55905_cuadv16n10_029
crossref_primary_10_15446_rsap_v25n3_107343
crossref_primary_10_3390_jcm13216626
crossref_primary_10_12688_f1000research_133999_3
crossref_primary_10_3390_jcm12020624
crossref_primary_10_3390_jcm10235594
crossref_primary_10_1155_2022_8373697
crossref_primary_10_1183_23120541_00141_2021
crossref_primary_10_1186_s12879_021_06970_3
crossref_primary_10_1038_s41598_022_17033_1
crossref_primary_10_1371_journal_pone_0279310
crossref_primary_10_1016_j_cegh_2024_101695
crossref_primary_10_20473_jn_v17i2_36170
crossref_primary_10_12968_ijtr_2022_0096
crossref_primary_10_1055_s_0043_1764467
crossref_primary_10_3390_ijerph192214739
crossref_primary_10_3390_healthcare12070730
crossref_primary_10_1055_a_1946_3230
crossref_primary_10_1007_s00103_022_03513_2
crossref_primary_10_1183_13993003_02174_2021
crossref_primary_10_1016_j_resmer_2022_100973
crossref_primary_10_1186_s41687_024_00748_2
crossref_primary_10_12688_f1000research_127398_1
crossref_primary_10_1093_cid_ciab352
crossref_primary_10_2196_30274
crossref_primary_10_3390_epidemiologia3010006
crossref_primary_10_3390_jcm11195904
crossref_primary_10_1080_13854046_2024_2379508
crossref_primary_10_1590_1809_2950_e22008824pt
crossref_primary_10_1136_bmjopen_2024_084202
crossref_primary_10_2196_33704
crossref_primary_10_1055_a_2059_4844
crossref_primary_10_1177_23969873221092538
crossref_primary_10_1016_j_ijosm_2022_04_004
crossref_primary_10_1038_s41598_023_30674_0
crossref_primary_10_1016_j_jbmt_2023_11_002
crossref_primary_10_2147_IJGM_S492772
crossref_primary_10_4187_respcare_12089
crossref_primary_10_1186_s13293_024_00609_z
crossref_primary_10_1016_j_bjpt_2023_100503
crossref_primary_10_1016_j_clinbiomech_2022_105797
crossref_primary_10_1055_a_1551_9734
crossref_primary_10_1080_17474086_2023_2277323
crossref_primary_10_3389_fmed_2021_750378
crossref_primary_10_1590_1809_2950_e22008824en
crossref_primary_10_1002_pmrj_13141
crossref_primary_10_1177_15500594221103834
crossref_primary_10_2196_44241
crossref_primary_10_3390_biomedicines12112445
crossref_primary_10_1080_09638288_2024_2303366
crossref_primary_10_1186_s12879_025_10729_5
crossref_primary_10_3390_healthcare10122577
crossref_primary_10_1177_11795735231195693
crossref_primary_10_1093_infdis_jiae270
crossref_primary_10_1016_j_pulmoe_2022_01_001
crossref_primary_10_1590_1413_81232025301_05682023
crossref_primary_10_3390_ijerph191811460
crossref_primary_10_1016_j_ft_2023_03_126
crossref_primary_10_1016_j_thromres_2022_11_006
crossref_primary_10_3390_jpm13091391
crossref_primary_10_1590_0102_311xen026623
crossref_primary_10_18203_issn_2454_2156_IntJSciRep20250388
crossref_primary_10_3389_fimmu_2024_1341600
crossref_primary_10_1186_s13063_024_08032_w
crossref_primary_10_3390_jcm11247338
crossref_primary_10_1590_0102_311xpt026623
crossref_primary_10_1016_j_iccn_2022_103366
crossref_primary_10_18093_0869_0189_2021_31_5_571_579
crossref_primary_10_1016_j_rpth_2024_102534
crossref_primary_10_1016_j_thromres_2021_08_012
crossref_primary_10_1038_s41598_024_71589_8
crossref_primary_10_1007_s44202_024_00204_8
crossref_primary_10_1136_bmjresp_2021_001136
crossref_primary_10_1055_s_0042_1749659
crossref_primary_10_1177_29768675241305102
crossref_primary_10_1007_s00508_025_02522_w
crossref_primary_10_1186_s40945_022_00147_0
crossref_primary_10_3390_healthcare11162277
crossref_primary_10_3390_biology10060469
crossref_primary_10_4274_tybd_galenos_2023_03360
crossref_primary_10_1016_j_arbres_2021_09_008
crossref_primary_10_1093_ptj_pzac090
crossref_primary_10_18093_0869_0189_2023_33_5_611_621
crossref_primary_10_31083_j_rcm2302053
Cites_doi 10.1016/j.jpainsymman.2016.10.370
10.1007/s11136-005-8661-z
10.1371/journal.pone.0211532
10.1186/1477-7525-2-51
10.2165/00019053-199304050-00006
10.1183/23120541.00542-2020
10.1136/thx.2004.030205
10.1007/s40273-016-0441-9
10.1038/s41586-020-2405-7
10.1016/j.thromres.2020.04.041
10.1001/archinte.167.12.1312
10.1126/science.abb3221
10.1016/j.thromres.2019.04.003
10.1016/j.jval.2016.01.003
10.1016/j.thromres.2020.03.020
10.3390/jcm9092946
10.1016/j.jclinepi.2010.02.006
10.1111/j.1440-1843.2010.01720.x
10.1001/jama.2020.2648
10.1089/jpm.2010.0438
10.1183/13993003.01494-2020
10.3390/jcm9123993
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7T2
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BENPR
BHPHI
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
M0S
M1P
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12955-021-01691-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE



Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals (WRLC)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1477-7525
EndPage 10
ExternalDocumentID oai_doaj_org_article_360c7196cb1041829fe20c4d5b767117
PMC7856622
A653683177
33536042
10_1186_s12955_021_01691_2
Genre Journal Article
GeographicLocations Belgium
Netherlands
United States--US
GeographicLocations_xml – name: Netherlands
– name: Belgium
– name: United States--US
GroupedDBID ---
0R~
29I
2WC
44B
53G
5VS
7X7
7XC
88E
8C1
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACHQT
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7T2
7XB
8FK
AZQEC
C1K
COVID
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c597t-65418a855f4c2e8b2df808e3d0b46a8a47d20f66f1cdee3fb32b486851798de23
IEDL.DBID M48
ISSN 1477-7525
IngestDate Wed Aug 27 01:30:39 EDT 2025
Thu Aug 21 14:12:43 EDT 2025
Fri Jul 11 08:39:37 EDT 2025
Fri Jul 25 03:45:45 EDT 2025
Mon Aug 11 06:00:10 EDT 2025
Tue Jun 10 20:49:29 EDT 2025
Fri Jun 27 04:19:26 EDT 2025
Mon Jul 21 05:44:33 EDT 2025
Tue Jul 01 04:06:47 EDT 2025
Thu Apr 24 23:01:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Functional status
SARS-CoV-2
Symptoms
Quality of life
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-65418a855f4c2e8b2df808e3d0b46a8a47d20f66f1cdee3fb32b486851798de23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1910-7695
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12955-021-01691-2
PMID 33536042
PQID 2491421791
PQPubID 44384
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_360c7196cb1041829fe20c4d5b767117
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7856622
proquest_miscellaneous_2486462833
proquest_journals_2491421791
gale_infotracmisc_A653683177
gale_infotracacademiconefile_A653683177
gale_incontextgauss_ISR_A653683177
pubmed_primary_33536042
crossref_primary_10_1186_s12955_021_01691_2
crossref_citationtrail_10_1186_s12955_021_01691_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-03
PublicationDateYYYYMMDD 2021-02-03
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Health and quality of life outcomes
PublicationTitleAlternate Health Qual Life Outcomes
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 1691_CR13
1691_CR12
D Hui (1691_CR18) 2017; 53
MM Versteegh (1691_CR21) 2016; 19
A Bardel (1691_CR26) 2019; 14
R Li (1691_CR3) 2020; 368
M Fortin (1691_CR25) 2006; 15
PSJ Miller (1691_CR23) 2016; 34
DS Hui (1691_CR6) 2005; 60
M Fortin (1691_CR24) 2004; 2
MC Reilly (1691_CR22) 1993; 4
FA Klok (1691_CR9) 2019; 178
FA Klok (1691_CR8) 2020; 56
LB Mokkink (1691_CR17) 2010; 63
YMJ Goërtz (1691_CR14) 2020; 6
S Flaxman (1691_CR4) 2020; 584
FA Klok (1691_CR11) 2020; 191
JC Ngai (1691_CR7) 2010; 15
Z Wu (1691_CR2) 2020; 323
1691_CR1
L Zeng (1691_CR19) 2011; 14
AW Vaes (1691_CR15) 2020; 9
GJAM Boon (1691_CR10) 2020; 190
R Meys (1691_CR16) 2020; 9
CM Tansey (1691_CR5) 2007; 167
1691_CR20
References_xml – volume: 53
  start-page: 630
  issue: 3
  year: 2017
  ident: 1691_CR18
  publication-title: J Pain Symptom Manag
  doi: 10.1016/j.jpainsymman.2016.10.370
– volume: 15
  start-page: 83
  issue: 1
  year: 2006
  ident: 1691_CR25
  publication-title: Qual Life Res
  doi: 10.1007/s11136-005-8661-z
– volume: 14
  start-page: e0211532
  issue: 2
  year: 2019
  ident: 1691_CR26
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0211532
– volume: 2
  start-page: 51
  year: 2004
  ident: 1691_CR24
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-2-51
– volume: 4
  start-page: 353
  issue: 5
  year: 1993
  ident: 1691_CR22
  publication-title: Pharmacoeconomics
  doi: 10.2165/00019053-199304050-00006
– ident: 1691_CR1
– volume: 6
  start-page: 00542
  issue: 4
  year: 2020
  ident: 1691_CR14
  publication-title: ERJ Open Res
  doi: 10.1183/23120541.00542-2020
– volume: 60
  start-page: 401
  issue: 5
  year: 2005
  ident: 1691_CR6
  publication-title: Thorax
  doi: 10.1136/thx.2004.030205
– volume: 34
  start-page: 1277
  issue: 12
  year: 2016
  ident: 1691_CR23
  publication-title: Pharmacoeconomics
  doi: 10.1007/s40273-016-0441-9
– volume: 584
  start-page: 257
  issue: 7820
  year: 2020
  ident: 1691_CR4
  publication-title: Nature
  doi: 10.1038/s41586-020-2405-7
– volume: 191
  start-page: 148
  year: 2020
  ident: 1691_CR11
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2020.04.041
– ident: 1691_CR12
– volume: 167
  start-page: 1312
  issue: 12
  year: 2007
  ident: 1691_CR5
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.167.12.1312
– volume: 368
  start-page: 489
  issue: 6490
  year: 2020
  ident: 1691_CR3
  publication-title: Science
  doi: 10.1126/science.abb3221
– volume: 178
  start-page: 59
  year: 2019
  ident: 1691_CR9
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2019.04.003
– volume: 19
  start-page: 343
  issue: 4
  year: 2016
  ident: 1691_CR21
  publication-title: Value Health
  doi: 10.1016/j.jval.2016.01.003
– volume: 190
  start-page: 45
  year: 2020
  ident: 1691_CR10
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2020.03.020
– volume: 9
  start-page: 2946
  issue: 9
  year: 2020
  ident: 1691_CR15
  publication-title: J Clin Med
  doi: 10.3390/jcm9092946
– ident: 1691_CR20
– volume: 63
  start-page: 737
  issue: 7
  year: 2010
  ident: 1691_CR17
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.02.006
– volume: 15
  start-page: 543
  issue: 3
  year: 2010
  ident: 1691_CR7
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2010.01720.x
– volume: 323
  start-page: 1239
  issue: 13
  year: 2020
  ident: 1691_CR2
  publication-title: JAMA
  doi: 10.1001/jama.2020.2648
– volume: 14
  start-page: 337
  issue: 3
  year: 2011
  ident: 1691_CR19
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2010.0438
– volume: 56
  start-page: 2001494
  issue: 1
  year: 2020
  ident: 1691_CR8
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01494-2020
– volume: 9
  start-page: 3993
  issue: 12
  year: 2020
  ident: 1691_CR16
  publication-title: J Clin Med
  doi: 10.3390/jcm9123993
– ident: 1691_CR13
SSID ssj0023225
Score 2.580799
Snippet An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on...
Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its...
Abstract Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 40
SubjectTerms Adult
Belgium
Committees
Convalescence
Coronaviruses
COVID-19
COVID-19 - physiopathology
COVID-19 - psychology
COVID-19 diagnostic tests
Cross-Sectional Studies
Demographic aspects
Disease
Domains
Evaluation
Female
Functional Status
Health aspects
Hospitalization
Humans
Hypotheses
Impairment
Indexing
Infections
Male
Medical ethics
Middle Aged
Netherlands
Quality of Life
Questionnaires
Reproducibility of Results
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Surveys and Questionnaires
Symptoms
Thromboembolism
Validation studies
Validity
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SU0HE-rlaSxTBg4RuPjabd2yrj9aDgrXSW9h82QeyT9i-_78zye7jLQW9eN1Mwu7MJDOTnfkNIe-lMDXEDZLhXyemNLZ5aYJhMugEHkbnfMhZvl_1-ZX6ct1c77T6wpywAg9cGHcsde1bUBPvIHAAZ3iRoqi9Co1rdct5riMHmzcFU2OohWo6lcgYfTyAVWuwEhlDZ73gTMzMUEbrv38m7xilecLkjgVaPiaPRteRnpRXPiAPYv-EPCz3brSUEz0lFjtwZkxYCjq0CuBk03Wi4OZR7MvLzr79vPjE-IIuwaCVe0CKDudmoJcgrkhXPc2YHHTYOLyjGShe1dJp3jNytfz84-ycjU0UmIdY4ZZhn2_TmaZJyotonAgJpBNlqJ3SnelUG0SdtE7chxhlclI4ZbTJSGYhCvmc7PXrPr4kVEkRo-rMItRBmQ6W5Z5z7WSCVSJXFeETT60fEcax0cVvmyMNo22RgwU52CwHKyrycTvnT8HX-Cv1KYpqS4nY2PkBaIwdNcb-S2Mq8g4FbRH9osf0ml_dZhjsxeV3e6IbqQ24VED0YSRKa_gG343VCsAJBMyaUR7OKGF7-vnwpE92PB4GCzEvVwKRYSvydjuMMzHlrY_rDdIYjYXDUlbkRVG_7XdLCcvDcVuRdqaYM8bMR_rVTQYPbw048EK8-h-cfE32Rd5TArb6IdkD7Y5vwEe7dUd5O94BruMx1w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gXJAQ4puOgQJC4oCiNR9N805oDJ42DiAxht4tar62J6F2rHv_P3bavq1C2rVxojZ2HNu1fybkvRSmBL9BMvzrxJTGNi9VMEwGncDCaJwPOcv3uz46Vd9W1WoMuPVjWuWkE7OiDp3HGPk-uAlcCQTT_HTxl2HXKPy7OrbQuEvuIXQZpnTVq2uHC4V1KpQxer-Hu63CemR0oPWCMzG7jDJm__-a-cbVNE-bvHEPLR-Rh6MBSQ8Gjj8md2L7hDwYom90KCp6Siz24czIsBQkaR3A1KZdomDsUezOyw5__D7-wviCLuFaG6KBFM3OTU9PgGmRrluakTlov3EYqekpBmzpNO8ZOV1-_XV4xMZWCsyDx3DFsNu3aUxVJeVFNE6EBDyKMpRO6cY0qg6iTFon7kOMMjkpnDLaZDyzEIV8Tnbaro0vCVVSxKgaswhlUKaBZbnnXDuZYJXIVUH4tKfWjzjj2O7ij83-htF24IMFPtjMBysK8nE752JA2biV-jOyakuJCNn5QXd5ZscDZ6UufQ3qxTtwOMGJWqQoSq9C5Wpdc14X5B0y2iIGRotJNmfNpu_t8clPe6ArqQ0YVkD0YSRKHXyDb8aaBdgJhM2aUe7NKOGQ-vnwJE92VBK9vRbpgrzdDuNMTHxrY7dBGqOxfFjKgrwYxG_73VLC8qB0C1LPBHO2MfORdn2eIcRrA2a8ELu3v9Yrcl_k0yLgKO-RHZDb-BpssCv3Jh-0f6WyKsg
  priority: 102
  providerName: ProQuest
Title Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19
URI https://www.ncbi.nlm.nih.gov/pubmed/33536042
https://www.proquest.com/docview/2491421791
https://www.proquest.com/docview/2486462833
https://pubmed.ncbi.nlm.nih.gov/PMC7856622
https://doaj.org/article/360c7196cb1041829fe20c4d5b767117
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfG9oKEEN8LjMogJB5QIP6I7T4gtJZNGxIDdRRVvFiJ7YxKUwrLKsF_z52TVIuYEC95qM-u4rvzfcT3O0JeCG4yiBtEil-dUqmwzUvuTSq8qsDDKErn4y3fE3U0lx8W-WKL9O2Oug1srg3tsJ_U_OL89a-fv9-Bwr-NCm_UmwZsVo51xhgYqzFL4UjeAcukUVE_ys1XBY7CG6uNtE51zvO-iObaNQaGKuL5_31qXzFbwyuVV2zU4R1yu3Mu6X4rDXfJVqjvkVttZo62BUf3icUenRE1loKULT244XRVUXAEKXbuTaefvh6_T9mYHoLJazOFFF3SdUNPgaGBLmsaUTtosy4xi9NQTObSft4DMj88-DI9Srs2C6mDaOIyxU7gpjB5XknHgym5r4B_QfislKowhdSeZ5VSFXM-BFGVgpfSKBOxznzg4iHZrld12CVUCh6CLMzYZ16aApZljjFVigpWCUwmhPV7al2HQY6tMM5tjEWMsi0fLPDBRj5YnpBXmzk_WgSOf1JPkFUbSkTPjj-sLs5sp4xWqMxpOHpcCcEoBFjjKvDMSZ-XWmnGdEKeI6Mt4mPUeAHnrFg3jT0-ndl9lQtlwOkCopcdUbWCd3BFV88AO4GQWgPKvQElKLAbDvfyZHv5txAVM8kROzYhzzbDOBMvxdVhtUYao7C0WIiEPGrFb_PeQsDycCAnRA8Ec7Axw5F6-T3Ci2sDLj7nj__jf5-QmzyqDAdd3yPbILzhKThpl-WI3NALDU8zZSOyMzk4-TwbxYTHKOokPGeTb38AOEk3NQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0KrKASSEeBMoxSAQBxQ1fsTxHirUB6tdWopEW7Q3N7GdshJKCukK8VP9RmacZNsIqbde47GVeN6TeRDyVnCdgN8gYvzrFEuFY15Sp2PhVAkWRl5YF7J8D9TkWH6epbMVctHXwmBaZS8Tg6B2tcUY-Qa4CUxybKb58exXjFOj8O9qP0KjJYs9__cPuGzN5nQX8PuO8_Gno51J3E0ViC0Yz-cxDr7WuU7TUlrudcFdCa_rhUsKqXKdy8zxpFSqZNZ5L8pC8EJqFWbYa-ex0QGI_FugeBPkqGx26eAhc_SFOVptNKBLU6x_RoddjVjMB8ovzAj4XxNcUYXDNM0rem98n9zrDFa61VLYA7Liq4fkbhvto20R0yNicO5n6ERLgXLnDkx7WpcUjEuK04Djna_fp7sxG9ExqNE2-kjRzF009BCIxNN5RUMnENosCowMNRQDxLTf95gc38glPyGrVV35Z4RKwb2XuR65xEmdw7HMMqYKUcIpnsmIsP5Oje36muN4jZ8m-DdamRYPBvBgAh4Mj8iH5Z6ztqvHtdDbiKolJHbkDg_q36emY3AjVGIzEGe2AAcXnLZR6XlipUuLTGWMZRF5g4g22HOjwqSe03zRNGZ6-M1sqVQoDYYcAL3vgMoavsHmXY0E3AS26RpArg0gQSjY4XJPT6YTSo25ZKGIvF4u405MtKt8vUAYrbBcWYiIPG3Jb_ndQsDxIOQjkg0Ic3Axw5Vq_iO0LM80uA2cP7_-tV6R25OjL_tmf3qw94Lc4YFzOIiRNbIKNOxfgv13XqwHpqPk5Ka5_B-9Tmed
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Construct+validity+of+the+Post-COVID-19+Functional+Status+Scale+in+adult+subjects+with+COVID-19&rft.jtitle=Health+and+quality+of+life+outcomes&rft.au=Machado%2C+Felipe+V+C&rft.au=Meys%2C+Roy&rft.au=Delbressine%2C+Jeannet+M&rft.au=Vaes%2C+Anouk+W&rft.date=2021-02-03&rft.issn=1477-7525&rft.eissn=1477-7525&rft.volume=19&rft.issue=1&rft.spage=40&rft_id=info:doi/10.1186%2Fs12955-021-01691-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-7525&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-7525&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-7525&client=summon